[PDF][PDF] Progress in atrial fibrillation ablation during 25 years of Europace journal

L Boersma, JG Andrade, T Betts, M Duytschaever… - Europace, 2023 - academic.oup.com
The first edition of Europace journal in 1999 came right around the time of the landmark
publication of the electrophysiologists from Bordeaux, establishing how elimination of …

Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation: the CABANA randomized clinical trial

DS Chew, Y Li, PA Cowper, KJ Anstrom, JP Piccini… - Circulation, 2022 - Am Heart Assoc
Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Reflections on the usefulness of today's atrial fibrillation ablation procedure endpoints and patient-reported outcomes

C Blomström-Lundqvist, V Svedung Wettervik - EP Europace, 2022 - academic.oup.com
The improvement of Patient-reported outcomes, such as health-related quality of life, is the
main indication for atrial fibrillation ablation. Despite this guideline derived indication for an …

[HTML][HTML] Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: A secondary …

A Verma, DE Haines, LV Boersma, N Sood, A Natale… - Heart rhythm, 2023 - Elsevier
Background Freedom from atrial arrhythmia (AA) recurrence≥ 30 seconds after pulsed field
ablation (PFA) in patients with atrial fibrillation (AF) was reported in PULSED AF (Pulsed …

Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden

VY Reddy, M Mansour, H Calkins, A d'Avila… - Journal of the American …, 2024 - Elsevier
Background The ADVENT randomized trial revealed no significant difference in 1-year
freedom from atrial arrhythmias (AA) between thermal (RF/Cryo) and pulsed field ablation …

Super and nonresponders to catheter ablation for atrial fibrillation: a quality-of-life assessment using patient reported outcomes

M Farwati, OM Wazni, KG Tarakji, M Diab… - Circulation …, 2021 - Am Heart Assoc
Background: Atrial fibrillation (AF) ablation targets improvement in quality of life (QoL). Data
is scarce on predictors of QoL improvement following ablation. We aimed to investigate the …

Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST‐END study

M Lo, D Nair, M Mansour, H Calkins… - Journal of …, 2023 - Wiley Online Library
Introduction Use of a novel magnetic sensor enabled optical contact force ablation catheter
has been established to be safe and effective for treatment of symptomatic drug‐refractory …

[HTML][HTML] Epidemiology, trends, utilization disparities, and outcomes of catheter ablation and its association with coronary vasospasm amongst patients with non …

SNS Yarrarapu, P Shah, B Iskander, A Mestre, A Desai… - Cureus, 2023 - ncbi.nlm.nih.gov
Background: Catheter ablation (CA) is an important curative treatment for non-valvular atrial
fibrillation (NVAF), however, nationwide data on its utilization and disparities is limited …

[HTML][HTML] Atrial fibrillation symptom reduction and improved quality of life following the hybrid convergent procedure: A CONVERGE trial subanalysis

J Gill, KJ Crossen, C Blauth, F Kerendi… - Annals of …, 2024 - ncbi.nlm.nih.gov
Background CONVERGE was a prospective, multicenter, randomized controlled trial that
evaluated the safety of Hybrid Atrial Fibrillation Convergent (HC) and compared its …

[HTML][HTML] The importance of arrhythmia burden for outcomes and management related to catheter ablation of atrial fibrillation

P Sánchez-Somonte, EE Gul… - Korean Circulation …, 2021 - synapse.koreamed.org
Atrial fibrillation (AF) ablation has been shown to be an effective treatment for AF, although
our understanding of AF ablation outcomes until now, has been based on AF recurrence as …